Kenneth S. Ramos (Chair), University of Louisville Health Sciences Center
Patricia A. Buffler, University of California, Berkeley
James S. Bus, Dow Chemical Company
Gregory J. Carr, Procter & Gamble
Joseph J. DeGeorge, Merck Pharmaceuticals
David J. Galas, Battelle
Linda E. Greer, Natural Resources Defense Council
Robert J. Griffin, Marquette University
Amy D. Kyle, University of California, Berkeley
Peter G. Lord, Johnson & Johnson
William B. Mattes, Critical Path Institute
Aubrey Milunsky, Boston University School of Medicine
Gilbert S. Omenn, University of Michigan
Frederica P. Perera, Columbia University
John Quackenbush, Dana-Farber Cancer Insitute, Harvard School of Public Health
Mark A. Rothstein, University of Louisville School of Medicine
Leona D. Samson, Massachusetts Institute of Technology
Martha S. Sandy, California Environmental Protection Agency
Todd Sherer, Emory University
Peter S. Spencer, Oregon Health Science University
Lawrence Sung, University of Maryland Law School
Mahlet G. Tadesse, University of Pennsylvania
Cheryl Lyn Walker, University of Texas
N. Leigh Anderson, Plasma Proteome Institute
Georgia M. Dunston, Howard University College of Medicine
David L. Eaton, University of Washington
Linda C. Fentiman, Pace University
William F. Greenlee, CIIT Centers for Health Research
John D. Groopman, Johns Hopkins Bloomberg School of Public Health
Casimir A. Kulikowski, Rutgers, The State University of New Jersey, New Brunswick
Serrine S. Lau, University of Arizona
Philip Leder, Harvard Medical School
John A. Moore, Hollyhouse, Inc.
George Orphanides, Syngenta
Bing Ren, University of California, San Diego
Ellen Kovner Silbergeld, Johns Hopkins Bloomberg School of Public Health
Thomas R. Skopek, Merck Research Laboratories
Russell D. Wolfinger, SAS Institute, Inc.
Timothy R. Zacharewski, Michigan State University